Summit Partners Public Asset Management, LLC Ani Pharmaceuticals Inc Transaction History

Summit Partners Public Asset Management, LLC

  • $2.79 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$26.91 - $47.15 $2.61 Million - $4.57 Million
-96,910 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$32.97 - $56.85 $3.2 Million - $5.51 Million
96,910 New
96,910 $4.47 Million

Others Institutions Holding ANIP

# of Institutions
210
Shares Held
18.2M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.02B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email